Nuvalent: Promising Data Continues to Validate Pipeline and Platforms (NASDAQ:NUVL)

This article was written by

Follow

Analyst Disclosure: We do not/have any equity, option or similar derivative positions in any of the companies mentioned and do not intend to initiate such positions in the next 72 hours. I wrote this article myself and it expresses my own opinions. I receive no compensation for this (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Although there are no personal account positions, SOME SHARES MENTIONED MAY ALREADY BE PART OF FAMILY AND ASSOCIATE PORTFOLIOS and retirement accounts such as IRAs and can be bought/sold within the next 72 hours. The mentioned shares may already be part of the portfolios of the Prudent Biotech, Prudent Healthcare or Prudent Small Cap models. As always, please do your due diligence. Biotechs and small caps have a higher risk of loss than the broader market. Opinions may change with time and additional data, without obligation to update. The companies mentioned here may not be favored in the future as market trends change and/or new information emerges and relevant portfolio updates will not be provided unless you are a model portfolio subscriber. PrudentBiotech.com, PrudentHealthcare.com, PrudentSmallCap.com, Graycell Advisors or any other associated names and entities are not registered investment advisors (RIAs) and publish quantitative model portfolios for investors and RIAs. The stocks mentioned in the article may in the past, present or future form part of the various model portfolios for subscribers. Past performance is no guarantee of future results. The information herein is provided for general informational purposes only and not as a recommendation and is not guaranteed to be complete or accurate.

Looking for Alpha’s reveal: Past performance is no guarantee of future results. No recommendation or advice is given as to whether any investment is suitable for any particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, a US broker or investment adviser, or an investment bank. Our analysts are third-party authors that include both professional and individual investors who may not be authorized or certified by any institute or regulatory body.